These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9758682)

  • 21. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells.
    Panyam J; Labhasetwar V
    Pharm Res; 2003 Feb; 20(2):212-20. PubMed ID: 12636159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
    Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
    J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of nanoparticle uptake into hair follicles in pig ear and human forearm.
    Raber AS; Mittal A; Schäfer J; Bakowsky U; Reichrath J; Vogt T; Schaefer UF; Hansen S; Lehr CM
    J Control Release; 2014 Apr; 179():25-32. PubMed ID: 24486055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy.
    Chen H; Zheng Y; Tian G; Tian Y; Zeng X; Liu G; Liu K; Li L; Li Z; Mei L; Huang L
    Nanoscale Res Lett; 2011 Dec; 6(1):4. PubMed ID: 27502629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomimetic mucin modified PLGA nanoparticles for enhanced blood compatibility.
    Thasneem YM; Rekha MR; Sajeesh S; Sharma CP
    J Colloid Interface Sci; 2013 Nov; 409():237-44. PubMed ID: 23978287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A.
    Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS; Vyas SP
    Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.
    Nakano K; Egashira K; Masuda S; Funakoshi K; Zhao G; Kimura S; Matoba T; Sueishi K; Endo Y; Kawashima Y; Hara K; Tsujimoto H; Tominaga R; Sunagawa K
    JACC Cardiovasc Interv; 2009 Apr; 2(4):277-83. PubMed ID: 19463437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
    Patil GB; Surana SJ
    J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
    Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
    Thomas C; Gupta V; Ahsan F
    Int J Pharm; 2009 Sep; 379(1):41-50. PubMed ID: 19524654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D; Mangal S; Goswami R; Jaganathan KS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative examination of adsorption of serum proteins on HSA- and PLGA-based nanoparticles using SDS-PAGE and LC-MS.
    Gossmann R; Fahrländer E; Hummel M; Mulac D; Brockmeyer J; Langer K
    Eur J Pharm Biopharm; 2015 Jun; 93():80-7. PubMed ID: 25813886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.